No adverse effects of statins on muscle function and health-related parameters in the elderly: An exercise study

Scandinavian Journal of Medicine and Science in Sports

Volumn 23, Issue 5, 2013, Pages 556-567

  Panayiotou, G ^a,b   Paschalis, V ^a,c   Nikolaidis, M G ^a,d   Theodorou, A A ^a,c   Deli, C K ^a,c   Fotopoulou, N ^a,c   Fatouros, I G ^e   Koutedakis, Y ^a,c,f   Sampanis, M ^d   Jamurtas, A Z ^a,c  

^a INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^b EUROPEAN UNIVERSITY CYPRUS   (Cyprus)

^c UNIVERSITY OF THESSALY   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^f UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Eccentric exercise; Hypercholesterolemia; Insulin resistance; Lipid profile; Muscle damage; Substrate oxidation

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE;

ADIPOSE TISSUE; AGED; ARTICLE; BODY CONSTITUTION; BODY MASS; CASE CONTROL STUDY; DRUG EFFECT; ECCENTRIC EXERCISE; ENERGY METABOLISM; EXERCISE; EXERCISE TEST; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LIPID PROFILE; LUNG VENTILATION; MALE; MEDICAL RECORD; MUSCLE INJURY; PHYSIOLOGY; SKELETAL MUSCLE; SUBSTRATE OXIDATION;

ECCENTRIC EXERCISE; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LIPID PROFILE; MUSCLE DAMAGE; SUBSTRATE OXIDATION;

ADIPOSE TISSUE; AGED; BODY CONSTITUTION; BODY MASS INDEX; CASE-CONTROL STUDIES; DIET RECORDS; ENERGY METABOLISM; EXERCISE; EXERCISE TEST; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MAXIMAL VOLUNTARY VENTILATION; MUSCLE, SKELETAL; PYRROLES;

EID: 84884713059     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2011.01437.x     Document Type: Article

References (69)

1. Armstrong RB. Initial events in exercise-induced muscular injury. Med Sci Sports Exerc 1990: 22: 429-435.
2. Asp S, Daugaard JR, Richter EA. Eccentric exercise decreases glucose transporter GLUT4 protein in human skeletal muscle. J Physiol 1995: 482 (Pt 3): 705-712.
3. Bates TR, Connaughton VM, Watts GF. Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother 2009: 10: 2973-2985.
4. Bottas R, Miettunen K, Komi PV, Linnamo V. Disturbed motor control of rhythmic movement at 2h and delayed after maximal eccentric actions. J Electromyogr Kinesiol 2010: 20: 608-618.
5. Branson RD, Johannigman JA. The measurement of energy expenditure. Nutr Clin Pract 2004: 19: 622-636.
6. Burleson MA, Jr, O'Bryant HS, Stone MH, Collins MA, Triplett-McBride T. Effect of weight training exercise and treadmill exercise on post-exercise oxygen consumption. Med Sci Sports Exerc 1998: 30: 518-522.
7. Christopher-Stine L. Statin myopathy: an update. Curr Opin Rheumatol 2006: 18: 647-653.
8. Chung J, Brass EP, Ulrich RG, Hiatt WR. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise. Clin Pharmacol Ther 2008: 83: 243-250.
9. Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 2002: 81: S52-S69.
10. Conboy IM, Conboy MJ, Smythe GM, Rando TA. Notch-mediated restoration of regenerative potential to aged muscle. Science 2003: 302: 1575-1577.
11. Dolezal BA, Potteiger JA, Jacobsen DJ, Benedict SH. Muscle damage and resting metabolic rate after acute resistance exercise with an eccentric overload. Med Sci Sports Exerc 2000: 32: 1202-1207.
12. Duncan CJ. The role of phospholipase A2 in calcium-induced damage in cardiac and skeletal muscle. Cell Tissue Res 1988: 253: 457-462.
13. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003: 27: 875-888.
14. Friden J, Seger J, Sjostrom M, Ekblom B. Adaptive response in human skeletal muscle subjected to prolonged eccentric training. Int J Sports Med 1983: 4: 177-183.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
16. Gadbut AP, Caruso AP, Galper JB. Differential sensitivity of C2-C12 striated muscle cells to lovastatin and pravastatin. J Mol Cell Cardiol 1995: 27: 2397-2402.
17. Grundy SM. Statin therapy in older persons: pertinent issues. Arch Intern Med 2002: 162: 1329-1331.
18. Gurr M, Harwood J, Frayn K. Lipids in cellular structures. 5th edn. Oxford: Blackwell, 2002: 286-297.
19. Hadley EC, Ory MG, Suzman R, Weindruch R, Fried L. Physical frailty: a treatable cause of dependence in old age. J Gerontol 1993: 48: B1-B88.
20. Hamelin BA, Turgeon J. Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 1998: 19: 26-37.
21. Hoppeler H. Exercise-induced ultrastructural changes in skeletal muscle. Int J Sports Med 1986: 7: 187-204.
22. Howatson G, Van Someren K, Hortobagyi T. Repeated bout effect after maximal eccentric exercise. Int J Sports Med 2007: 28: 557-563.
23. Howatson G, van Someren KA. Evidence of a contralateral repeated bout effect after maximal eccentric contractions. Eur J Appl Physiol 2007: 101: 207-214.
24. Igel M, Sudhop T, von Bergmann K. Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin. J Clin Pharmacol 2002: 42: 835-845.
25. Israeli A, Raveh D, Arnon R, Eisenberg S, Stein Y. Lovastatin and elevated creatine kinase: results of rechallenge. Lancet 1989: 1: 725.
26. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc 2006: 54: 56-62.
27. Jeukendrup AE, Wallis GA. Measurement of substrate oxidation during exercise by means of gas exchange measurements. Int J Sports Med 2005: 26 (Suppl 1): S28-S37.
28. Kaufmann P, Torok M, Zahno A, Waldhauser KM, Brecht K, Krahenbuhl S. Toxicity of statins on rat skeletal muscle mitochondria. Cell Mol Life Sci 2006: 63: 2415-2425.
29. Kerksick CM, Kreider RB, Willoughby DS. Intramuscular adaptations to eccentric exercise and antioxidant supplementation. Amino Acids 2010: 39: 219-232.
30. Kirwan JP, Hickner RC, Yarasheski KE, Kohrt WM, Wiethop BV, Holloszy JO. Eccentric exercise induces transient insulin resistance in healthy individuals. J Appl Physiol 1992: 72: 2197-2202.
31. Knol B. Top ten/twenty best selling drugs 2009. 2009. http://knol.google.com/k/top-ten-twenty-best-selling-drugs-2009#.
32. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999: 282: 2340-2346.
33. LaStayo P, McDonagh P, Lipovic D, Napoles P, Bartholomew A, Esser K, Lindstedt S. Elderly patients and high force resistance exercise - a descriptive report: can an anabolic, muscle growth response occur without muscle damage or inflammation? J Geriatr Phys Ther 2007: 30: 128-134.
34. Lastayo PC, Reich TE, Urquhart M, Hoppeler H, Lindstedt SL. Chronic eccentric exercise: improvements in muscle strength can occur with little demand for oxygen. Am J Physiol 1999: 276: R611-R615.
35. Lau WY, Nosaka K. Effect of vibration treatment on symptoms associated with eccentric exercise-induced muscle damage. Am J Phys Med Rehabil 2011: 90: 648-657.
36. Lavender AP, Nosaka K. Comparison between old and young men for changes in makers of muscle damage following voluntary eccentric exercise of the elbow flexors. Appl Physiol Nutr Metab 2006: 31: 218-225.
37. MacIntoch BR, Gardiner PF, McComas AJ. Skeletal Muscle form and function. Champaign, IL: Human Kinetics, 1996.
38. McHugh MP, Connolly DA, Eston RG, Gleim GW. Exercise-induced muscle damage and potential mechanisms for the repeated bout effect. Sports Med 1999: 27: 157-170.
39. Mehta JL, Bursac Z, Hauer-Jensen M, Fort C, Fink LM. Comparison of mortality rates in statin users versus nonstatin users in a United States veteran population. Am J Cardiol 2006: 98: 923-928.
40. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 2002: 57: B359-B365.
41. Moosmann B, Behl C. Selenoprotein synthesis and side-effects of statins. Lancet 2004: 363: 892-894.
42. Muthalib M, Lee H, Millet GY, Ferrari M, Nosaka K. Comparison between maximal lengthening and shortening contractions for biceps brachii muscle oxygenation and hemodynamics. J Appl Physiol 2010: 109: 710-720.
43. Nair KS. Aging muscle. Am J Clin Nutr 2005: 81: 953-963.
44. Nakahara K, Kuriyama M, Sonoda Y, Yoshidome H, Nakagawa H, Fujiyama J, Higuchi I, Osame M. Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study. Toxicol Appl Pharmacol 1998: 152: 99-106.
45. Nikolaidis MG, Paschalis V, Giakas G, Fatouros IG, Sakellariou GK, Theodorou AA, Koutedakis Y, Jamurtas AZ. Favorable and prolonged changes in blood lipid profile after muscle-damaging exercise. Med Sci Sports Exerc 2008: 40: 1483-1489.
46. Nosaka K, Aldayel A, Jubeau M, Chen TC. Muscle damage induced by electrical stimulation. Eur J Appl Physiol 2011: 111: 2427-2437.
47. Nosaka K, Newton M, Sacco P. Delayed-onset muscle soreness does not reflect the magnitude of eccentric exercise-induced muscle damage. Scand J Med Sci Sports 2002: 12: 337-346.
48. Oscai LB, Essig DA, Palmer WK. Lipase regulation of muscle triglyceride hydrolysis. J Appl Physiol 1990: 69: 1571-1577.
49. Paiva H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, Laakso J, Lehtimaki T, von Bergmann K, Lutjohann D, Laaksonen R. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther 2005: 78: 60-68.
50. Paschalis V, Koutedakis Y, Jamurtas AZ, Mougios V, Baltzopoulos V. Equal volumes of high and low intensity of eccentric exercise in relation to muscle damage and performance. J Strength Cond Res 2005: 19: 184-188.
51. Paschalis V, Nikolaidis MG, Giakas G, Jamurtas AZ, Owolabi EO, Koutedakis Y. Position sense and reaction angle after eccentric exercise: the repeated bout effect. Eur J Appl Physiol 2008: 103: 9-18.
52. Paschalis V, Nikolaidis MG, Giakas G, Theodorou AA, Sakellariou GK, Fatouros IG, Koutedakis Y, Jamurtas AZ. Beneficial changes in energy expenditure and lipid profile after eccentric exercise in overweight and lean women. Scand J Med Sci Sports 2010: 20: e269-e277.
53. Paschalis V, Nikolaidis MG, Theodorou AA, Panayiotou G, Fatouros IG, Koutedakis Y, Jamurtas AZ. A weekly bout of eccentric exercise is sufficient to induce health-promoting effects. Med Sci Sports Exerc 2011: 43: 64-73.
54. Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, Vladutiu GD, England JD. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med 2002: 137: 581-585.
55. Proske U, Allen TJ. Damage to skeletal muscle from eccentric exercise. Exerc Sport Sci Rev 2005: 33: 98-104.
56. Rivlin RS. Keeping the young-elderly healthy: is it too late to improve our health through nutrition? Am J Clin Nutr 2007: 86: 1572S-1576S.
57. Roberts MD, Kerksick CM, Dalbo VJ, Hassell SE, Tucker PS, Brown R. Molecular attributes of human skeletal muscle at rest and after unaccustomed exercise: an age comparison. J Strength Cond Res 2010: 24: 1161-1168.
58. Roth SM, Martel GF, Ivey FM, Lemmer JT, Tracy BL, Hurlbut DE, Metter EJ, Hurley BF, Rogers MA. Ultrastructural muscle damage in young vs. older men after high-volume, heavy-resistance strength training. J Appl Physiol 1999: 86: 1833-1840.
59. Schick BA, Laaksonen R, Frohlich JJ, Paiva H, Lehtimaki T, Humphries KH, Cote HC. Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin Pharmacol Ther 2007: 81: 650-653.
60. Sirvent P, Mercier J, Vassort G, Lacampagne A. Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle. Biochem Biophys Res Commun 2005: 329: 1067-1075.
61. Straburzynska-Migaj E, Gwizdala A, Siniawski A, Ochotny R, Grajek S. Oxygen uptake efficiency slope correlates with brain natriuretic peptide in patients with heart failure. Cardiol J 2010: 17: 362-366.
62. Tee JC, Bosch AN, Lambert MI. Metabolic consequences of exercise-induced muscle damage. Sports Med 2007: 37: 827-836.
63. Theodorou AA, Nikolaidis MG, Paschalis V, Koutsias S, Panayiotou G, Fatouros IG, Koutedakis Y, Jamurtas AZ. No effect of antioxidant supplementation on muscle performance and blood redox status adaptations to eccentric training. Am J Clin Nutr 2011: 93: 1373-1383.
64. Thompson PD, Clarkson PM, Rosenson RS. The national lipid association statin safery task force muscle safety expert panel. Am J Cardiol 2006: 97: 69C-76C.
65. Tiwari R, Pathak K. Statins therapy: a review on conventional and novel formulation approaches. J Pharm Pharmacol 2011: 63: 983-998.
66. Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Strandberg T, Tonstad S, Gylling H. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev 2010: (7): CD006401.
67. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004: 27: 1487-1495.
68. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, Day NE. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003: 6: 407-413.
69. Weerakkody NS, Percival P, Hickey MW, Morgan DL, Gregory JE, Canny BJ, Proske U. Effects of local pressure and vibration on muscle pain from eccentric exercise and hypertonic saline. Pain 2003: 105: 425-435.